 |
 |
 |
 |
 |
|
|
| Article 1 to 10 out of 153
|
|
-
Spectral granted IDE approval by U.S. FDA to conduct pivotal trial for Toraymyxin
(08 Mar 2010)
Spectral Diagnostics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for Toraymyxin(TM), a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, ......
-
Butalco announces it is to produce its first cellulosic ethanol in summer 2010
(25 Feb 2010)
This summer, Butalco will use its proprietary new yeast technology to produce biofuel from agricultural waste in a pilot plant in Southern Germany. Butalco's new microbial catalysts will enable up to 30% increased yields in cellulosic ethanol ......
-
Actavis expands manufacturing site in Iceland
(10 Feb 2010)
Production at Actavis Hafnarfjordur site, Iceland
Actavis has announced plans to expand its manufacturing site in Iceland, increasing capacity at the site by 50%. Fifty new jobs will be created as a result. The Hafnarfjordur, Iceland manufacturing site exports 95% of its products. After ......
-
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP manufacturing agreement
(10 Feb 2010)
Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient (API) for Vitae's lead product candidate, VTP-27999. Solvias will provide ongoing process ......
-
EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
(08 Feb 2010)
EUCODIS Bioscience announced that it has received a cash injection of EUR 2 million from existing shareholders. The Company will use these funds to swiftly add new enzyme families to its product portfolio and to accelerate the development of ......
-
BRAIN and Bayer Schering Pharma co-operate on biotechnological steroid-production
(04 Feb 2010)
BRAIN AG and Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds ......
-
Bioamber Commissions World's First Renewable Succinic Acid Plant
(25 Jan 2010)
Bioamber, a joint venture between US-based DNP Green Technology andFrance-based ARD (Agro-industrie Recherches et Développements), announces the successful start-up and commissioning of the world's first bio-based succinic acid plant. Since ......
-
Merck Builds New Production Plant for Pharmaceutical Raw Materials
(22 Jan 2010)
New plant for the production of inorganic salts by crystallization
Merck KGaA announced that it has started construction work at its Darmstadt site on a production plant for the manufacture of inorganic salts. This will increase capacity by around 50% compared to the production lines currently being used. The ......
-
Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil
(13 Jan 2010)
Expansion of Cooperation With Diabetes Leader Novo Nordisk
The Gerresheimer Group has set up a new facility for medical plastic systems in Indaiatuba (Brazil). The plant is to commence operations early in 2010. On the basis of a long-term cooperation agreement with Novo Nordisk, components will be ......
-
Sanofi-aventis doubles syringe production capacity and diversifies vaccine production at the Le Trait Manufacturing Plant
(15 Dec 2009)
Sanofi-aventis launched its new production units at the Le Trait site in a ceremony attended by Jean-Marie Aline, Mayor of Le Trait, Christophe Bouillon, Member of the French National Assembly for Seine-Maritime, Christopher A. Viehbacher, ......
|
|
|
|
|